These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8020494)

  • 1. Comparison of the solution structures of the chimeric peptides galanin(1-12)-Ala-neuropeptide Y(25-36)amide and galanin(1-12)-Pro-neuropeptide Y(25-36)amide.
    Arvidsson K; Langel U; Ehrenberg A
    Eur J Biochem; 1994 Jun; 222(2):573-81. PubMed ID: 8020494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors.
    Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A
    Biochemistry; 1993 Aug; 32(30):7787-98. PubMed ID: 7688568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
    Kahl U; Langel U; Bartfai T; Grundemar L
    Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amide.
    Saar K; Mahlapuu R; Laidmäe E; Valkna A; Kahl U; Karelson E; Langel U
    Regul Pept; 2001 Oct; 102(1):15-9. PubMed ID: 11600206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure by 1H and dynamics by natural abundance 13C NMR of a receptor recognising peptide derived from a C-terminal fragment of neuropeptide Y.
    Arvidsson K; Jarvet J; Allard P; Ehrenberg A
    J Biomol NMR; 1994 Sep; 4(5):653-72. PubMed ID: 7919952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New high affinity peptide antagonists to the spinal galanin receptor.
    Xu XJ; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T
    Br J Pharmacol; 1995 Oct; 116(3):2076-80. PubMed ID: 8640348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycine residue in cyclic lactam analogues of galanin(1-16)-NH2 is important for stabilizing an N-terminal helix.
    Carpenter KA; Schmidt R; Yue SY; Hodzic L; Pou C; Payza K; Godbout C; Brown W; Roberts E
    Biochemistry; 1999 Nov; 38(46):15295-304. PubMed ID: 10563815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational properties of the proline region of porcine neuropeptide Y by CD and 1H-nmr spectroscopy.
    Chu SS; Velde DV; Shobe D; Balse P; Doughty MB
    Biopolymers; 1995 Jun; 35(6):583-93. PubMed ID: 7766824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key motif to gain selectivity at the neuropeptide Y5-receptor: structure and dynamics of micelle-bound [Ala31, Pro32]-NPY.
    Bader R; Rytz G; Lerch M; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2002 Jun; 41(25):8031-42. PubMed ID: 12069594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent stabilized solution structures of galanin and galanin analogs, studied by circular dichroism spectroscopy.
    Ohman A; Lycksell PO; Andell S; Langel U; Bartfai T; Gräslund A
    Biochim Biophys Acta; 1995 Jun; 1236(2):259-65. PubMed ID: 7540871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational analysis of neuropeptide Y segments by CD, NMR spectroscopy and restrained molecular dynamics.
    Gurrath M; Bisello A; Bottazzo K; Chung CW; Mammi S; Peggion E
    J Pept Sci; 1996; 2(3):176-93. PubMed ID: 9231326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations.
    Beck-Sickinger AG; Wieland HA; Wittneben H; Willim KD; Rudolf K; Jung G
    Eur J Biochem; 1994 Nov; 225(3):947-58. PubMed ID: 7957231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of human neuropeptide Y.
    Monks SA; Karagianis G; Howlett GJ; Norton RS
    J Biomol NMR; 1996 Dec; 8(4):379-90. PubMed ID: 9008359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats.
    Cabrele C; Langer M; Bader R; Wieland HA; Doods HN; Zerbe O; Beck-Sickinger AG
    J Biol Chem; 2000 Nov; 275(46):36043-8. PubMed ID: 10944518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR.
    Lindberg M; Jarvet J; Langel U; Gräslund A
    Biochemistry; 2001 Mar; 40(10):3141-9. PubMed ID: 11258929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
    Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the presynaptic (Y2) receptor-specific neuropeptide Y analog ANA-NPY.
    Barden JA; Cuthbertson RM; Potter EK
    Biochim Biophys Acta; 1995 Jul; 1250(1):83-9. PubMed ID: 7612657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.